Management
Once a diagnosis of KD is established, it is important that the child is admitted to the hospital for investigations and treatment. The mainstay of treatment is the administration of intravenous immunoglobuhn, as this has proved to be beneficial in reducing the risk of developing cardiac comphcations from 20-40% to approximately 5% when given within 10 days of the onset of the illness (Kim et al, 2009). A further dose of immunoglobulin and additional immune-modulating therapy may be necessary for refractory cases, which account for up to 20% of patients